Enzyme Converts Kidney Blood Types for More Transplants
Author: University of Cambridge
Published: 2022/08/17 - Updated: 2026/01/24
Publication Details: Peer-Reviewed, Research, Study, Analysis
Category Topic: Medical - Related Publications
Page Content: Synopsis - Introduction - Main - Insights, Updates
Synopsis: This research, published as a peer-reviewed study from the University of Cambridge, demonstrates a breakthrough technique using enzymes as "molecular scissors" to convert blood type markers on deceased donor kidneys to the universal O type. The findings hold particular significance for patients with chronic kidney disease who face extended wait times, especially those from ethnic minority communities who represent 33% of transplant waiting lists but account for only 9% of organ donations. The study addresses a critical healthcare disparity by potentially increasing the pool of compatible donor organs, offering patients like those with stage three chronic kidney disease - who may wait six to ten years for a match - substantially improved access to life-saving transplants - Disabled World (DW).
- Definition: Kidney Transplant
A kidney transplant or renal transplant is the organ transplant of a kidney into a patient with end-stage kidney disease (ESRD). Kidney transplant is typically classified as deceased-donor (formerly known as cadaveric) or living-donor transplantation depending on the source of the donor organ. Living-donor kidney transplants are further characterized as genetically related (living-related) or non-related (living-unrelated) transplants, depending on whether a biological relationship exists between the donor and recipient.
Introduction
Researchers at the University of Cambridge have successfully altered the blood type of three deceased donor kidneys in a ground-breaking discovery that could have major implications for kidney patients. The project, funded by charity Kidney Research UK, could increase the supply of kidneys available for transplant, particularly within ethnic minority groups who are less likely to be a match for the majority of donated kidneys.
Main Content
Professor Mike Nicholson and Ph.D. student Serena MacMillan used a normothermic perfusion machine - a device that connects with a human kidney to pass oxygenated blood through the organ to preserve it for future use better - to flush blood infused with an enzyme through the deceased kidney.
The enzyme acted like "molecular scissors" to remove the blood type markers that line the blood vessels of the kidney resulting in the organ being converted to the most common O type.
A kidney from someone with an A blood type cannot be transplanted to someone with a B blood type, nor the other way around. But changing the blood type to the universal O will allow more transplants to occur as O can be used for people with any blood group.
"It's very exciting to think about how this could potentially impact so many lives" - Serena MacMillan.
"Our confidence was boosted after we applied the enzyme to a piece of human kidney tissue and saw very quickly that the antigens were removed," said MacMillan.
"After this, we knew that the process was feasible, and we just had to scale up the project to apply the enzyme to full-size human kidneys. By taking B-type human kidneys and pumping the enzyme through the organ using our normothermic perfusion machine, we saw in a few hours that we had converted a B-type kidney into an O type."
The discovery could be particularly impactful for people from ethnic minority groups who often wait a year longer for a transplant than Caucasian patients.
People from minority communities are more likely to have B-type blood, and with current low donation rates from these populations, there are not enough kidneys to go around. In 2020/21, just over 9% of total organ donations came from black and minority ethnic donors, while black and minority ethnic patients make up 33% of the kidney transplant waiting list.
The Cambridge team now needs to see how the newly changed O-type kidney will react to a patient's usual blood type in their normal blood supply. The perfusion machine allows them to do this before testing people. They can take the kidneys which have been changed to the O type, use the machine to introduce different blood types, and monitor how the kidney might react, simulating the process of transplant into the body.
"We now need to look at whether our methods can be successful in a clinical setting" - Prof Mike Nicholson
"One of the biggest restrictions to who a donated kidney can be transplanted to is the fact that you have to be blood group compatible," said Nicholson, professor of transplant surgery.
"The reason for this is that you have antigens and markers on your cells that can be either A or B. Your body naturally produces antibodies against the ones you don't have."
"Blood group classification is also determined via ethnicity, and ethnic minority groups are more likely to have the rarer B type. After successfully shifting blood group to the universal O type, we now need to look at whether our methods can be successful in a clinical setting and ultimately carried through to transplantation."

Printable chart showing possible blood type of a child according to their parents blood group.
Dr. Aisling McMahon, executive director of research at Kidney Research UK, said:
"The research that Mike and Serena are undertaking is potentially game-changing. Seeing the team's progress in such a short time is imposing, and we are excited to see the next steps."
"As an organisation, we are committed to funding research that transforms treatments and tackles health inequalities. We know that people from minority ethnic groups can wait much longer for a transplant as they are less likely to be a blood-type match with the organs available. This research offers a glimmer of hope to over 1,000 people from minority ethnic groups who are waiting for a kidney," McMahon said.
After testing the reintroduction of other blood types, the team in Cambridge will look at how the approach might be used in a clinical setting. Having made great progress in such a short space of time, they are hopeful for the future.
The full paper on Mike and Serena's work is set to be published in the British Journal of Surgery in the coming months.

Printable chart showing compatible blood types for receiving blood transfusions.
"A transplant would give me a second chance at a healthy life" - Ayesha.
Ayesha was diagnosed with stage three chronic kidney disease in 1998 when she was pregnant with her first child. She didn't think much of it while she enjoyed her time being a mother, but her kidneys deteriorated rapidly during the pandemic.
She was told she would need a transplant, but she might have to wait double or even triple the time for a kidney than a Caucasian person. Consultants estimated that she might have to wait six to ten years to receive one.
Ayesha said:
"They explained that because of my ethnicity, my wait for a deceased donor would be longer than for a white person. The reason being my background - being the Muslim community and other faiths and cultures often don't agree to be organ donors."
"I feel sad at the thought of waiting so long for a transplant, I understand a transplant isn't a cure, but it would make my body a lot stronger and give me a second chance at a healthy life."
She has recently started volunteering for Kidney Research UK under the charity's peer educator scheme, a program that recruits trusted community members to talk openly about kidney disease.
"In the Muslim communities, kidney disease is common yet still a taboo subject at the same time," said Ayesha.
"People's religious beliefs play an imperative role in making life-changing decisions. Even after the law changed, so everyone was automatically made an organ donor, many decided to opt-out."
"The research will offer so much hope to minority groups still waiting for a transplant and could help to save many lives. Convincing communities that research such as this and organ donation is beneficial is so crucial to improving and saving lives."
Ayesha continues to hope for a donor and that through her education, more people will come forward and offer her and others like her the chance at a better life.
Insights, Analysis, and Developments
Editorial Note: The implications of this enzymatic blood type conversion extend far beyond the laboratory bench. While the technique still requires clinical validation and long-term safety studies, it represents a practical solution to one of transplant medicine's most persistent challenges - the tyranny of blood type compatibility. For the thousand-plus minority patients currently waiting, this isn't just about scientific innovation; it's about reducing a disparity that has quietly persisted for decades. The next phase will reveal whether these converted kidneys can withstand the immune challenges of transplantation, but the initial success offers something rarely found in medical research: a straightforward answer to a complex problem that disproportionately affects those already facing the longest odds - Disabled World (DW).Attribution/Source(s): This peer reviewed publication was selected for publishing by the editors of Disabled World (DW) due to its relevance to the disability community. Originally authored by University of Cambridge and published on 2022/08/17, this content may have been edited for style, clarity, or brevity.